Project documents | Pirtobrutinib for treating chronic lymphocytic leukaemia or small lymphocytic lymphoma after 1 or more BTK inhibitors [ID6269] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 128 KB)

Published:

11 April 2025
Final stakeholder list (PDF 96 KB)

Published:

11 April 2025
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 108 KB)

Published:

11 April 2025
Equality impact assessment (scoping) (PDF 51 KB)

Published:

11 April 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 213 KB)

Published:

21 February 2025
Draft matrix of consultees and commentators post referral (PDF 302 KB)

Published:

21 February 2025

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6269

Draft scope post referral (PDF 212 KB)

Published:

28 February 2024
Draft matrix post referral (PDF 181 KB)

Published:

28 February 2024